on OXURION (EBR:OXUR)
Oxurion Approves Agenda at Annual Shareholders' Meeting
On June 1, 2026, Oxurion NV held its annual shareholders' meeting in Leuven, Belgium. The biopharmaceutical company announced that all items on the meeting's agenda were approved by the shareholders. The details and documents related to the meeting are accessible on Oxurion's official website.
Oxurion focuses on acquiring majority stakes in promising European pharmaceutical subcontractors. Its goal is to form an integrated group serving healthcare entities. The company's headquarters are located in Leuven.
Oxurion acknowledges the risks and uncertainties related to forward-looking statements mentioned in the release. Therefore, no assurance is given on their materialization. The press release is not an offer for sales or purchase of securities.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news